NEW YORK — Only 18 percent of pharmaceutical advertisements
are compliant with Food and Drug Administration (FDA) guidelines, according to a study
led by Mount Sinai School of Medicine researchers.
Of the 192 pharmaceutical advertisements in biomedical
journals that were analyzed, only 18 percent were compliant with Food and Drug
Administration (FDA) guidelines, and over half failed to quantify serious risks
The study is published online in the journal Public Library
of Science (PLoS) One.
research has consistently shown that journal advertising is the most profitable
form of drug marketing, with an estimated return on investment of $5 for every
dollar spent,” said Dr. Deborah Korenstein, lead author of the study and associate
professor of medicine at Mount Sinai School of Medicine. “Our study, the first
in nearly 20 years to provide a systematic assessment of the adherence of U.S.
advertisements to FDA guidance, shows that the current system is not in the
best interest of the health of the public.”